Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcg Metals Regulatory News (ACG)

Share Price Information for Acg Metals (ACG)

Share Price is delayed by 15 minutes
Get Live Data
1,670.00    0.00 (0.00%)
Bid:
1,710.00
Ask:
1,750.00
Spread: 40.00 (2.339%)
Market Cap: £386.40m
ACG Live PriceLast checked at - London Stock Exchange

Intraday Acg Metals Share Chart

Form 8.5 (EPT/RI)

11 Dec 2025 09:23

RNS Number : 1920L
Canaccord Genuity Limited
11 December 2025
 

-

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ACG Metals Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected to the Offeror

 

(d) Date dealing undertaken:

10 December 2025

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

CLS A ORD NPV (DI)

Sales

851

1,050p

1,050p

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

Date of disclosure:

11 December 2025

Contact name:

David Baker

Telephone number:

020 7523 4656

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERZZMMZLMMGKZG
Date   Source Headline
5th Sep 20248:10 amRNSAdmission to Trading and Total Voting Rights
5th Sep 20248:00 amRNSReadmission - ACG Acquisition Company Limited
3rd Sep 20245:01 pmRNSClosing of Acquisition
30th Aug 20248:34 amRNSSupplement Approval & Timeline Update
29th Aug 202411:47 amRNSFINALISATION OF ACQUISITION FUNDING
28th Aug 20247:01 amRNSMarket Update on Acquisition Timeline
27th Aug 20247:00 amRNSMarket Update On Acquisition Funding
23rd Aug 20247:00 amRNSMarket Update on Acquisition Funding and Timeline
19th Aug 20245:33 pmRNSMarket Update
7th Aug 202411:56 amRNSEGM Circular
7th Aug 202411:39 amRNSPublication of Prospectus and Notice of EGM
26th Jul 20247:00 amRNSExtension of Redemption Period
18th Jul 20247:00 amRNSAcquisition Announcement
12th Jul 20244:23 pmRNSTR-1: Notification of major holdings
28th Jun 20247:00 amRNSExtension of the Acquisition Deadline
29th Apr 20247:12 amRNSResignation of Independent Director
28th Mar 20245:00 pmRNSTR-1: Notification of Major Holdings
27th Mar 20247:00 amRNSTR-1: Notification of Major Holdings
13th Mar 20249:37 amRNSTR-1: Notification of Major Holdings
7th Mar 202410:37 amRNSTR-1: Notification of Major Holdings
1st Mar 20244:37 pmRNSTotal Voting Rights
21st Feb 20247:13 amRNSTR-1: Notification of Major Holdings
8th Feb 20247:22 amRNSTotal Voting Rights
5th Feb 20247:00 amRNSFinal Redemption Price
1st Feb 20247:00 amRNSAppointment of CFO and Finance Director
26th Jan 20247:07 amRNSExtension of Acquisition Deadline
16th Jan 20243:33 pmRNSResults of EGM and the Redemption Elections
8th Jan 20247:13 amRNSExtension EGM Notice
8th Jan 20247:12 amRNSShareholders Circular and Notice of EGM
5th Jan 20242:07 pmRNSTR-1: Notification of Major Holdings
2nd Jan 202411:52 amRNSTR-1: Notification of Major Holdings
29th Dec 202310:17 amRNSTR-1: Notification of Major Holdings
15th Dec 20231:54 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
13th Dec 20234:30 pmRNSTR-1: Notification of Major Holdings
12th Dec 202310:08 amRNSResignation of Acting Chief Financial Officer
10th Nov 202312:23 pmRNSChairman Resignation & Appointment of New Director
1st Nov 20234:45 pmRNSTotal Voting Rights
30th Oct 20237:13 amRNSTR-1: Notification of Major Holdings
27th Oct 20234:43 pmRNSTotal Voting Rights
25th Oct 20231:53 pmRNSResults of the Extension EGM
25th Oct 20231:53 pmRNSTR-1: Notification of Major Holdings
24th Oct 20237:00 amRNSResults of Redemption Elections
19th Oct 20232:45 pmRNSFurther Irrevocable Undertakings & CFO Resignation
17th Oct 20236:30 pmRNSExtension EGM Notice
17th Oct 20236:23 pmRNSExtension of Acquisition Deadline
12th Oct 20237:00 amRNSUpdate on the Company
28th Sep 20235:59 pmRNSTermination of Acquisition Agreement
21st Aug 20237:00 amRNSFurther Update on Acquisition
10th Aug 20237:53 amRNSUpdate on Acquisition
18th Jul 20237:00 amRNSUpdate on Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.